<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objectives of the 'Task Force on Catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid Syndrome</z:e> (APS) and Non-criteria APS Manifestations' were to assess the clinical utility of the international consensus statement on classification criteria and treatment guidelines for the catastrophic APS, to identify and grade the studies that analyse the relationship between the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and the non-criteria APS manifestations and to present the current evidence regarding the accuracy of these non-criteria APS manifestations for the detection of patients with APS </plain></SENT>
<SENT sid="1" pm="."><plain>This article summarizes the studies analysed on the catastrophic APS, APS <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and heart valve lesions, and presents the recommendations elaborated by the Task Force after this analysis </plain></SENT>
</text></document>